TrialDiabetes, obesity & metabolism2018

Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial.

Ildiko Lingvay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.